7 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
risks, and therapy should ... hypoglycemia risk and effect ... #pharmacology #pharmacotherapy ... table #comparison #management ... #medications #diabetes
Diabetes Morning Hyperglycemia - Dawn Phenomenon vs Somogyi Effect 

When patients FBG's are elevated each morning
Diabetes Morning ... attempts at adjusting medication ... or decrease the medication ... Hyperglycemia #Diagnosis ... #Management #Endocrinology
Orthopedic Dislocations (Shoulder, Elbow and Hip) - Diagnosis and Management Summary
Shoulder Dislocation
 • Fall on the
Elbow and Hip) - Diagnosis ... and Management ... rotation) • Anterior ... Affected hip and knee ... head is pushed down
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... Patients should ... upset as a side effect ... #semaglutide #Diabetes ... #Pharmacology #
Digoxin Pharmacology and Monitoring

 • Digoxin’s half-life is 30-45 hours in healthy adults
 • When monitoring
Digoxin Pharmacology ... , blood levels should ... be drawn no sooner ... significant GI side effects ... Monitoring #toxicology #management
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... health-care provider diagnosis ... HIV-infected persons should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... and molecular diagnostic ... empiric treatment should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology